Tag Archives: Health Care

FDA Week: For Biologics, A Name Isn’t Just A Name (Jim Greenwood op-ed)

Jim Greenwood

What is in a name? Names help make medicinal products more easily distinguishable by doctors, pharmacists and patients. When you are talking about biologics, complex medicines that are manufactured using living organisms, and biosimilars, medicines that are similar to, but not the same as, innovator biologics, naming is a significant consideration. As a pathway for biosimilars approval is implemented, a clear priority should be to craft a naming convention that both contributes to patient safety Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , ,

National Black HIV/AIDS Awareness Day

National Black HIV/AIDS Awareness Day

In the United States, more than one million people are infected with HIV, with an estimated 50,000 newly diagnosed each year. While African Americans make up only 12-14 percent of the U.S. population they account for nearly half (44 percent) of all the new HIV infections in the U.S. (CDC). Today, as the United States observes National Black HIV/AIDS Awareness Day, we’d like to take a look at some of the scientific advancements made in Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Cancer Insurance Checklist: Guía de Cobertura Médica para Personas con Cáncer

20070112

As the world marks World Cancer Day and the U.S. continues to implement the Affordable Care Act, the Cancer Support Community (CSC) is pleased to announce the launch of a Spanish language version of the successful resource, the Cancer Insurance Checklist. This easy-to-use guide is available to assist people with cancer, a history of cancer or at risk for cancer choose a health insurance plan. The need is great.  Nearly a third (31.1 percent) of Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

BIO Responds to GPhA Citizen Petition on Biosimilars Naming

FDA115x76

Last September, the Generic Pharmaceutical Association (GPhA) filed a Citizen Petition with the FDA, requesting the FDA to “implement its INN naming policy equally to all biologics” and to require “all biologics approved under the Section 351(k) pathway…share the same INN [International Nonproprietary Name] as the RPP [reference protein product]” (the GPhA Petition). Today, BIO submitted our response. Contrary to the GPhA Petition, BIO believes that the legal, regulatory, and scientific principles related to biologics and biosimilarity Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

IPAB: Bad Medicine for Patient Care

DC in Fall

The Independent Payment Advisory Board is bad medicine for patient care, deficit reduction and containing Medicare costs. This board, consisting of 15 bureaucrats appointed by the President, has been given the power to make decisions affecting patients’ quality of care, with almost no oversight and no means for challenging its decisions. IPAB must be repealed. There is widespread support among patient advocacy groups and members of Congress on both sides of the aisle for full Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , ,